About Us

Ecoticket is a R&D company, spin-off of the University of Minho, Portugal, that works in collaboration with the University and other University spin-off companies in networking, such as Ecofoot, with a team of experienced researchers on the development of dyes and the functionality of textile materials, mentored by Professor Jaime Rocha Gomes.

Collaborating with the textile industry for more than 30 years, Professor Jaime Rocha Gomes and his team carry out breakthrough research having been awarded on 2011 for his R&D work on silica nanoparticles  applied to dyes the BES Grand National Prize and having several international patents, namely on previous work on microcapsules (2007). Ecoticket has since then registered two patents on the antimicrobial and mosquito repellent.

Ecoticket’s main focus since 2008 has been the development of antimicrobial and mosquito repellent technology.

Ecoticket has since then registered two patents on the antimicrobial and mosquito repellent. Ecoticket’s main focus since 2008 has been the development of antimicrobial and mosquito repellent technology. Other fields of research are: microcapsules, optical brightners, low temperature bleaching, washfastness of disperse and reactive dyes, ink-jet printing, dyes and dyeing studies.

Technology

Our technology is the result of years of intense research in functional textile materials and development of technical innovations that can be applied to different industries.

The basis of our technology is to produce highly-efficient products aimed at ecological processes and non-toxicological final products.

None of the materials we develop have or are applied with any harmful substances such as heavy metals, formaldehyde or halogens.

Mosquito Repellent

Patented technology to keep mosquitoes away (PT107001)

Our mosquito repellent technology assures great protection against mosquitoes being an outstanding asset for the fight against diseases like malaria, dengue and yellow fever. Every year those diseases are responsible for millions of deaths worldwide, having a devastating impact on the population of the affected regions. The main risk groups are children and the elderly.

From the point-of-view of governments, organizations and companies, the mosquito-borne diseases increase healthcare costs dramatically and have very negative effects on economic development. The risk of disease can be significantly reduced by preventing mosquito bites by applying a mosquito repellent to mosquito nets, textiles and other products.

This technology is a very effective mosquito repellent that the team began developing in 2008 at the University of Minho has been continuously optimized since then. This innovative technology can be applied to a wide range of products and materials, such as mosquito nets, textiles, paints and coatings. For mosquito nets the repellent properties are kept for 20 washes, according to WHO recommendations.

THE TECHNOLOGY

THE TECHNOLOGY

Patented combination of biocompatible active substances.

APPLICATIONS

APPLICATIONS

Mosquito nets, textiles and clothes (such as military uniforms, bed-linen, curtains, sweat-shirts), paints and varnishes, tents, sleeping bags and nets.

ADVANTAGES

ADVANTAGES

Applicable in several industries. Nontoxic and biocompatible. Proven effectiveness in laboratory testing. Great durability.

Antimicrobial

Patented pending technology to keep bacteria away (PT107002)

Annually, this results in 5000 deaths with a cost to the National Health Service of a billion pounds. Hospital-acquired infections, also known as nosocomial infections, represent a major problem all over the world. A study conducted in Britain shows that one in ten patients will acquire a nosocomial infection.

Annually, this results in 5000 deaths with a cost to the National Health Service of a billion pounds. Hospital-acquired infections, also known as nosocomial infections, represent a major problem all over the world. A study conducted in Britain shows that one in ten patients will acquire a nosocomial infection.

In the United States of America The Centers for Disease Control and Prevention estimated approximately 1.7 million hospital-associated infections, causing or contributing to 99 000 deaths each year, with the annual cost ranging from 4.5 billion to 11 billion dollars.

THE TECHNOLOGY

THE TECHNOLOGY

Patented combination of biocompatible active substances.

APPLICATIONS

APPLICATIONS

Hospital clothing, textiles and clothing, underwear and socks, uniforms of doctors, nurses, auxiliary staff and health technicians.

ADVANTAGES

ADVANTAGES

Reduced cost of application. Applicable in several industries. Nontoxic and biocompatible. Proven effectiveness in laboratories. Great durability (> 90 washes).

Get In Touch With Us

Your Name (required)

Your Email (required)

Subject

Your Message